send to a friend by email
2019-02-18
According to the financial statements of Jerusalem Pharmaceuticals JPH for the year 2018, Net profit after tax of the period reached 6,095,827 USD Compared with Net profit after tax 6,163,670 USD for 2017, a net decrease in profit of 1.10%.Total assets of the company reached 63,592,520 USD compared with total assets of 61,625,755 USD at the end of year 2017, a net increase of 3.19%.Total liabilities of the company reached 12,665,036 USD compared with total liabilities of 12,237,751 USD at the end of year 2017, a net increase of 3.49%. Net ownership equity of the company reached 50,927,484 USD (Including Non-Controlling Interests of 2,429,612 USD) compared with total owner equity of 49,388,004 USD (Including Non-Controlling Interests of 851,077 USD) at the end of year 2017, a net increase of 3.12%.
|
|